Skip to main content
Erschienen in: Digestive Diseases and Sciences 10/2019

03.05.2019 | Original Article

Patients with Non-Hodgkin’s Lymphoma Are at Risk of Adenomatous Colon Polyps

verfasst von: Hamzah Abu-Sbeih, Ellie Chen, Osman Ahmed, Niharika Mallepally, Phillip Lum, Wei Qiao, Hun Ju Lee, Robert Bresalier, Lan Sun Wang, Brian Weston, Gottumukkala S. Raju, Yinghong Wang

Erschienen in: Digestive Diseases and Sciences | Ausgabe 10/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Patients with non-Hodgkin’s lymphoma (NHL) are frequently referred for colonoscopy to evaluate gastrointestinal symptoms during their treatment course. Here, we described the rate of colonic adenomas in patients with NHL.

Methods

This was a retrospective study of patients with NHL who underwent colonoscopy after being diagnosed with NHL between January 2000 and December 2017.

Results

Of the 17,938 patients who had been diagnosed with NHL in the study period, 2176 met the inclusion criteria. The mean age at the time of colonoscopy was 61 years. Most patients were male (61%). Overall, 1273 polyps were detected in 811 patients (37%). Sessile serrated adenomas were detected in 102 (5%) patients. The overall ADR was 12% in patients younger than 40 years of age (n = 103), 26% in patients aged 40–50 (n = 251), 34% in patients aged 51–60 (n = 630), and 43% in patients older than 60 (n = 1212). Most polyps were located in the right colon (63%), and 101 (8%) were larger than 1 cm. Villous adenomatous features were present in 1% of polyps, while high-grade dysplasia was detected in 22%. Invasive adenocarcinoma was identified in 4%. The median interval from lymphoma diagnosis to adenoma detection was 1.4 years (interquartile range 0.5–3.8 years). A repeat colonoscopy was performed in 343 patients. The overall ADR on repeat colonoscopy was 30%. Cox regression analysis revealed that age (hazards ratio 1.04; 95% confidence interval 1.03–1.05; P < 0.001) and male sex (hazards ratio 1.35; 95% confidence interval 1.13–1.60; P = 0.001) were independent factors associated with worse overall survival. By contrast, screening colonoscopy was associated with longer survival duration (hazards ratio 0.48; 95% confidence interval 0.36–0.63; P < 0.001).

Conclusion

The ADR in NHL patients aged 40–50 years was equivalent to that reported in the literature in non-cancer patients aged 50–70 years. Early screening colonoscopy may be warranted in NHL patients younger than 50 years. Screening colonoscopy significantly improved the overall survival of patients with NHL.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Stewart SLWJ, Kato I. A population-based study of colorectal cancer histology in the United States, 1998–2001. Cancer. 2006;107:1128–1141.CrossRefPubMed Stewart SLWJ, Kato I. A population-based study of colorectal cancer histology in the United States, 1998–2001. Cancer. 2006;107:1128–1141.CrossRefPubMed
4.
Zurück zum Zitat Cummings OW. Pathology of the adenoma-carcinoma sequence: from aberrant crypt focus to invasive carcinoma. Semin Gastrointest Dis. 2000;11:229–237.PubMed Cummings OW. Pathology of the adenoma-carcinoma sequence: from aberrant crypt focus to invasive carcinoma. Semin Gastrointest Dis. 2000;11:229–237.PubMed
5.
Zurück zum Zitat Hamilton SR. The adenoma-adenocarcinoma sequence in the large bowel: variations on a theme. J Cell Biochem. 1992;16g:41–46.CrossRef Hamilton SR. The adenoma-adenocarcinoma sequence in the large bowel: variations on a theme. J Cell Biochem. 1992;16g:41–46.CrossRef
6.
Zurück zum Zitat Brenner HHM, Stegmaier C. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies. Gut. 2007;56:1585–1589.CrossRefPubMedPubMedCentral Brenner HHM, Stegmaier C. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies. Gut. 2007;56:1585–1589.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Hisabe THF, Matsui T. Development and progression of colorectal cancer based on follow-up analysis. Dig Endosc. 2014;26:73–77.CrossRefPubMed Hisabe THF, Matsui T. Development and progression of colorectal cancer based on follow-up analysis. Dig Endosc. 2014;26:73–77.CrossRefPubMed
8.
Zurück zum Zitat Winawer SJFR, Miller L. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594.CrossRefPubMed Winawer SJFR, Miller L. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594.CrossRefPubMed
10.
Zurück zum Zitat Zauber AGWS, O’Brien MJ. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. NEJM. 2012;366:687–696.CrossRefPubMed Zauber AGWS, O’Brien MJ. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. NEJM. 2012;366:687–696.CrossRefPubMed
15.
16.
Zurück zum Zitat Force UPST. Screening for colorectal cancer, US preventive services task force recommendation statement. JAMA. 2016;315:2564–2575.CrossRef Force UPST. Screening for colorectal cancer, US preventive services task force recommendation statement. JAMA. 2016;315:2564–2575.CrossRef
17.
Zurück zum Zitat Society AC. Colorectal cancer facts and figures 2017–2019. In: Society AC, ed. Atlanta; 2017. p. 11–15. Society AC. Colorectal cancer facts and figures 2017–2019. In: Society AC, ed. Atlanta; 2017. p. 11–15.
19.
Zurück zum Zitat Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg. 1961;49:80–89.CrossRefPubMed Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg. 1961;49:80–89.CrossRefPubMed
20.
Zurück zum Zitat Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer. 1978;42:693–707.CrossRef Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer. 1978;42:693–707.CrossRef
21.
Zurück zum Zitat Sud Amit TH, Sundquist K. Risk of second cancer in Hodgkin Lymphoma survivors and influence of family history. J Clin Oncol. 2017;35:1584–1590.CrossRefPubMedPubMedCentral Sud Amit TH, Sundquist K. Risk of second cancer in Hodgkin Lymphoma survivors and influence of family history. J Clin Oncol. 2017;35:1584–1590.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Strul HKR, Leshno M. The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40–80 years. Am J Gastroenterol. 2006;101:255–262.CrossRefPubMed Strul HKR, Leshno M. The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40–80 years. Am J Gastroenterol. 2006;101:255–262.CrossRefPubMed
24.
Zurück zum Zitat Hemmasi GSM, Zamani F. Prevalence of colorectal adenoma in an average-risk population aged 40–50 versus 50–60 years. Eur J Cancer Prev. 2015;24:386–390.CrossRefPubMed Hemmasi GSM, Zamani F. Prevalence of colorectal adenoma in an average-risk population aged 40–50 versus 50–60 years. Eur J Cancer Prev. 2015;24:386–390.CrossRefPubMed
25.
Zurück zum Zitat Diamond SJEB, Jiang Z. Adenoma detection rate increases with each decade of life after 50 years of age. Gastrointest Endosc. 2011;74:135–140.CrossRefPubMed Diamond SJEB, Jiang Z. Adenoma detection rate increases with each decade of life after 50 years of age. Gastrointest Endosc. 2011;74:135–140.CrossRefPubMed
26.
Zurück zum Zitat Facciorusso ADMM, Serviddio G. Factors associated with recurrence of advanced colorectal adenoma after endoscopic resection. Clin Gastroenterol Hepatol. 2016;14:1148–1154.CrossRefPubMed Facciorusso ADMM, Serviddio G. Factors associated with recurrence of advanced colorectal adenoma after endoscopic resection. Clin Gastroenterol Hepatol. 2016;14:1148–1154.CrossRefPubMed
27.
Zurück zum Zitat Bonithon-Kopp CPF, Fenger C. Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum. 2004;47:323–333.CrossRefPubMed Bonithon-Kopp CPF, Fenger C. Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum. 2004;47:323–333.CrossRefPubMed
28.
Zurück zum Zitat Jang ESKJ, Jung YJ. Clinical and endoscopic predictors of colorectal adenoma recurrence after colon polypectomy. Turk J Gastroenterol. 2013;24:476–482.CrossRefPubMed Jang ESKJ, Jung YJ. Clinical and endoscopic predictors of colorectal adenoma recurrence after colon polypectomy. Turk J Gastroenterol. 2013;24:476–482.CrossRefPubMed
30.
Zurück zum Zitat Baras NDS, Haberland J. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990–2012). Br J Haematol. 2017;177:226–242.CrossRefPubMed Baras NDS, Haberland J. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990–2012). Br J Haematol. 2017;177:226–242.CrossRefPubMed
31.
Zurück zum Zitat Rossi CJJ, Mounier M. Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma. Leuk Lymphoma. 2015;56:2876–2882.CrossRefPubMed Rossi CJJ, Mounier M. Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma. Leuk Lymphoma. 2015;56:2876–2882.CrossRefPubMed
Metadaten
Titel
Patients with Non-Hodgkin’s Lymphoma Are at Risk of Adenomatous Colon Polyps
verfasst von
Hamzah Abu-Sbeih
Ellie Chen
Osman Ahmed
Niharika Mallepally
Phillip Lum
Wei Qiao
Hun Ju Lee
Robert Bresalier
Lan Sun Wang
Brian Weston
Gottumukkala S. Raju
Yinghong Wang
Publikationsdatum
03.05.2019
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 10/2019
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05629-z

Weitere Artikel der Ausgabe 10/2019

Digestive Diseases and Sciences 10/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.